SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Long-Term Study Proves Tamoxifen Helps Prevent Breast Cancer
November 16, 2005
 · 
1 min read
Drug Development
At 50, Tylenol Gains Steam On Safety Image
November 1, 2005
 · 
1 min read
Drug Development
Cancer Drug Found To Cut Some Relapses By Half
October 20, 2005
 · 
1 min read
Drug Development
Myfortic Better For Kidney Patients
October 19, 2005
 · 
1 min read
Drug Development
International Breast Cancer Prevention Study Launches In The USA And Canada
October 19, 2005
 · 
1 min read
Drug Development
National Cancer Institute Halts Drug Trial
October 19, 2005
 · 
1 min read
Drug Development
Cipro Beats Augmentin In Treating Urinary Tract Infections
October 19, 2005
 · 
1 min read
Drug Development
Companies Debate Arthritis Drug Safety At FDA; Whistleblower To Air New Pain Drug Analysis
October 19, 2005
 · 
1 min read
Drug Development
Drug Trial Targets Bowel Cancer
October 19, 2005
 · 
1 min read
Drug Development
Kaiser Permanente Halts Prescriptions Of Bextra
October 19, 2005
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Centocor Ortho Biotech Inc.: REMICADE(R) Study Results Show Greater Steroid-Free Remission and Mucosal Healing Compared With Conventional Immunomodulator Azathioprine in Treatment of Crohn’s Disease
April 15, 2010
 · 
11 min read
Drug Development
UCB, Inc. New Data Presented at the American Academy of Neurology Meeting Showed That Neupro(R) (Rotigotine Transdermal System) Improved Both Motor and Non-Motor Symptoms of Parkinson’s Disease
April 14, 2010
 · 
10 min read
Drug Development
Eli Lilly and Company’s ALIMTA(R) Recommended by Special Health Authority in United Kingdom as Maintenance Therapy for Advanced, Nonsquamous Non-Small Cell Lung Cancer
April 2, 2010
 · 
9 min read
Drug Development
Novo Nordisk A/S: Switching to Once-Daily Victoza(R) (Liraglutide [rDNA Origin] Injection) from Exenatide Further Improves Blood Sugar Control in Patients with Type 2 Diabetes
March 30, 2010
 · 
2 min read
Drug Development
FDA Issues Merck & Co., Inc. Warning for High Doses of Zocor
March 22, 2010
 · 
1 min read
Drug Development
U.S. FDA Says Takeda Pharmaceutical Co. Ltd. Sleep Drug Promotion Misleads
March 22, 2010
 · 
1 min read
Drug Development
ViroPharma Incorporated: Scientific Data Relating to Cinryze(TM) (C1 Esterase Inhibitor [Human]) Presented at First International Congress of the Southern European Allergy Society
March 19, 2010
 · 
4 min read
Drug Development
AstraZeneca PLC: New PLATO Sub-Analysis of CABG Patients Presented at American College of Cardiology
March 16, 2010
 · 
5 min read
Drug Development
Boston Scientific Corporation Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack
March 16, 2010
 · 
6 min read
Drug Development
Novartis Corporation’s Drug Tekturna Fails to Help After Heart Attack According to Study
March 16, 2010
 · 
1 min read
Drug Development
PERSEUS Trial Results Demonstrate Positive Safety and Efficacy Outcomes for Boston Scientific Corporation’s Novel Platinum Chromium TAXUS(R) Element(TM) Stent System
March 15, 2010
 · 
4 min read
Drug Development
Bristol-Myers Squibb Company (JOBS), Sanofi-Aventis (France)'s Plavix Gets New U.S. FDA Warning
March 15, 2010
 · 
9 min read
Drug Development
Novartis Corporation Drugs Fail to Help High-Risk Patients
March 15, 2010
 · 
1 min read
Drug Development
AstraZeneca PLC Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma
March 12, 2010
 · 
3 min read
Drug Development
FDA Approves Eisai Inc.'s Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS)
March 12, 2010
 · 
6 min read
Drug Development
FDA Rules Out Thigh Fracture Link with Bisphosphonate, Including Medications such as Merck & Co., Inc.'s Fosamax
March 11, 2010
 · 
1 min read
Drug Development
Bristol-Myers Squibb Company and AstraZeneca PLC Announce the Commencement of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus Trial (SAVOR-TIMI 53)
March 9, 2010
 · 
1 min read
Drug Development
Cumberland Pharmaceuticals: New Data from Caldolor(R) Study in Burn Patients to be Presented at 42nd Annual Meeting of The American Burn Association
March 2, 2010
 · 
1 min read
Drug Development
PharmAthene, Inc.: Data Show Valortim(R) Anthrax Anti-Toxin May Augment Immune System’s Ability to Destroy Anthrax Bacteria
February 24, 2010
 · 
6 min read
Drug Development
GlaxoSmithKline Responds to US Senate Committee on Finance Report on Avandia
February 24, 2010
 · 
3 min read
Load More